John R Lake – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emaillakex009umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

5 Active
27 Finished

32 results

Active
Vertical Sleeve Gastrectomy for Treatment of NASH: a pilot randomized control trial
Ikramuddin, S., Adeyi, O., Billington, C. J., Connett, J. E., Holker, E. G., Klatt, N. R. & Lake, J. R.
NIH Natl Inst of Diabetes/Dig/Kidney Dis
7/14/21 → 5/31/24
Project: Research project
Scientific Registry of Transplant Recipients
Lake, J. R.
Hennepin Healthcare Research Institute
9/21/20 → 9/20/22
Project: Research project
2017-AAR-010: ALFAPUMP SYSTEM IN THE TREATMENT OF REFRACTORY OR RECURRENT ASCITES: A MULTICENTER SINGLE ARM WITHIN SUBJECT CROSSOVER DESIGN PIVOTAL STUDY (THE POSEIDON STUDY)
Lake, J. R.
SEQUANA MEDICAL
9/11/19 → 9/30/24
Project: Research project
Hepatic Energy Fluxes, NASH, and Vertical Sleeve Gastrectomy
Ikramuddin, S., Amin, K., Bolan, P. J., Chauhan, A., Connett, J. E., Crawford, P., Lake, J. R. & d'Avignon, D.
NIH Natl Inst of Diabetes/Dig/Kidney Dis
8/1/19 → 5/31/22
Project: Research project
A 52-week, placebo-controlled, randomized, Phase 3 study to evaluate the safety and efficacy of seladelpar in subjects with primary biliary cholangitis (PBC) and an inadequate response to or an intolerance to ursodeoxycholic acid (UDCA)
Lake, J. R.
CYMABAY THERAPEUTICS, INC
9/1/18 → 8/30/22
Project: Research project
Finished
CB8025-21845: A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple CenterStudy To Evaluate The Safety, Tolerability, And Efficacy Of Seladelpar AdministeredFor 24 Weeks In Adult Subjects With Primary Sclerosing Cholangitis
Lake, J. R.
CYMABAY THERAPEUTICS, INC
1/29/20 → 7/30/20
Project: Research project
Scientific Registry of Transplant Recipients (SRTR)
Lake, J. R.
Hennepin Healthcare Research Institute
9/21/15 → 9/20/21
Project: Research project
Open-label Study to Evaluate the Safety and Efficacy
Lake, J. R.
AbbVie
7/1/15 → 10/31/16
Project: Research project
Multicenter, Prospective Evaluation of the Cepheid Xpert
Lake, J. R.
Beckman Coulter, Inc.
3/3/14 → 4/30/18
Project: Research project
MASTER CLINICAL TRIAL AGREEMENT
Lake, J. R.
SC LIVER RESEARCH CONSORTIUM, LLC.
2/5/14 → 2/4/19
Project: Research project
A Randomized, Global, Double-blind, Placebo-controlled,
Lake, J. R.
EISAI MEDICAL RESEARCH INC.
10/21/13 → 6/30/17
Project: Research project
A Multi-Center, Double-Blind, Randomized, Controlled
Lake, J. R.
CUMBERLAND PHARMACEUTICALS, INC.
10/7/13 → 6/30/16
Project: Research project
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ran
Lake, J. R.
SALIX PHARMACEUTICALS, INC.
9/26/13 → 12/27/16
Project: Research project
Multicenter, Randomized Phase 2B Study to Evaluate the E
Lake, J. R.
OCERA THERAPEUTICS, INC.
8/12/13 → 3/31/17
Project: Research project
A Phase 2, Multicenter, Open-Label Study to Investigate
Lake, J. R.
Gilead Sciences, Inc.
7/12/13 → 12/31/15
Project: Research project
Scientific Registry of Transplant Recipients (SRTR)
Lake, J. R.
Hennepin Healthcare Research Institute
6/1/13 → 9/20/15
Project: Research project
A Randomized, Open-Label, Multicenter, Controlled Study
Thompson, J. A. & Lake, J. R.
VITAL THERAPIES, INC.
5/17/12 → 6/30/20
Project: Research project
A Phase 2, Randomized, Multicenter, Placebo-Controlled,
Lake, J. R.
EISAI MEDICAL RESEARCH INC.
12/22/11 → 8/3/12
Project: Research project
A Multi-Center, Randomized, Placebo-Controlled, Double-B
Lake, J. R.
IKARIA THERAPEUTICS, LLC
8/3/10 → 12/31/13
Project: Research project
A 24-month randomized, multicenter study, evaluating eff
Lake, J. R.
NOVARTIS PHARMACEUTICALS CORPORATION
3/22/10 → 9/30/13
Project: Research project
A 24 Month, multi-center, open-lable randomized, control
Lake, J. R.
Novartis Pharma AG
7/2/09 → 1/4/12
Project: Research project
A Phase 2, Randmized, Multicenter, Placebo-Controlled, D
Lake, J. R.
EISAI MEDICAL RESEARCH INC.
4/6/09 → 12/31/13
Project: Research project
Optimal Long-Term Outcome of Chronic Hepatitis B
Smith, C., Hassan, M. A. & Lake, J. R.
Mayo Clinic
9/30/08 → 5/31/15
Project: Research project
A Phase 2, Open-Label, Multi-Center, Randomized Trial to
Lake, J. R.
LIFECYCLE PHARMA
9/10/08 → 2/10/12
Project: Research project
A Phase 2, Randomized, Double-Blind, Placebo-Controlled
Lake, J. R.
Hyperion Therapeutics
2/1/08 → 2/4/09
Project: Research project
A phase II, open-label, multi-center,prospective, random
Lake, J. R.
LIFECYCLE PHARMA
1/3/08 → 12/31/10
Project: Research project
A Phase II, Open-Label, Multi-Center Prospective, Conver
Lake, J. R. & Humar, A.
CTI CLINICAL TRIAL SERVICES, INC.
10/22/07 → 12/31/08
Project: Research project
A Open-Label Phase II Extension Study for Patients Compl
Lake, J. R. & Humar, A.
CTI CLINICAL TRIAL SERVICES, INC.
10/22/07 → 6/30/10
Project: Research project
Evaluation of Belatacept as First-Line Immunosuppression
Lake, J. R.
BRISTOL-MYERS SQUIBB COMPANY
8/10/07 → 12/31/15
Project: Research project
A Phase 2, Double-Blind, Multi-Center, Randomized Study
Lake, J. R.
Gilead Sciences, Inc.
12/31/05 → 12/12/12
Project: Research project
REFINE: Randomized, evaluation of fibrosis due to hepati
Lake, J. R.
NOVARTIS PHARMACEUTICALS CORPORATION
9/14/05 → 9/30/10
Project: Research project
A Prospective, Randomized, Multicenter, Open-Label, Comp
Lake, J. R.
ROCHE LAB INC
1/10/05 → 3/31/10
Project: Research project